Inspections, Compliance, Enforcement, and Criminal Investigations
Mave Enterprises, Inc - Close Out Letter 8/9/11
| Public Health Service Food and Drug Administration |
Los Angeles District |
CERTIFIED MAIL
RETURN RECEIPT REQUESTED
August 09, 2011
Ms. Amy E. Grawitsky, President
Mave Enterprises, Inc.
11555 Cantara St. Ste B-E
North Hollywood, CA 91605-1652
Dear Ms. Grawitsky:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter 27-11 dated February 16, 2011. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/s/
Alonza E. Cruse, Director
Los Angeles District





Department of Health and Human Services

